unknown
Stage
1
Investors
About
Agios Pharmaceuticals is a publicly traded biopharmaceutical company that discovers and develops investigational medicines to treat cancer and rare genetic diseases, with scientific expertise in cellular metabolism. The company has multiple clinical and preclinical programs and has brought oncology precision medicines to market.
Explore Agios Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.